Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nu Holdings Ltd (NU) vs UnitedHealth Group Inc (UNH) Price & Performance

Nu Holdings LtdTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Nu Holdings Ltd vs UnitedHealth Group Inc — how do they compare? Nu Holdings Ltd trades at $16.12 (market cap $74.30B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 4.5× Nu Holdings Ltd's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Nu Holdings Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nu Holdings Ltd for 53 Days and UnitedHealth Group Inc for 97 Days on average.

NUUNH
Market Cap
$74.30B$332.96B
Volume
80,294,8057,273,749
Sector
FinancialsHealth
52-Week High
$18.76$436.35
52-Week Low
$11.60$259.02
Typical Hold Time
53 Days97 Days
Enterprise Value
$96.91B$374.82B
Dividend Yield
—2.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nu Holdings Ltd

NU Holdings Ltd. (NU) is trading at $15.38, down 1.28% on the day, with a bullish technical signal from moving averages but a neutral reading from oscillators. The company demonstrates strong fundamental growth, with revenue increasing from $3.0B in 2022 to $10.63B in 2025 and net income turning positive to $2.87B. Recent news highlights market volatility around acquisition speculation, but the core business in Brazilian digital banking remains robust.

The outlook for NU is positive, supported by rapid customer growth and expanding profitability, though risks include credit concentration and integration challenges from potential acquisitions. Analyst consensus is bullish with a $16.53 price target, suggesting potential upside from the current price.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.

UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NU
46% Buy54% Sell
Avg holding period · 53 Days
UNH
71% Buy29% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About Nu Holdings Ltd

Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.

Read more on NU →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →